SCHEMBL918644

SCHEMBL918644

CC(=O)CCC(=O)ON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15561401 0.97 ALDH1A1 (0.53)
SCHEMBL29010926 0.97 ALDH1A1 (0.53)
SCHEMBL29019041 0.97 ALDH1A1 (0.53)
SCHEMBL28558844 0.97 ALDH1A1 (0.53)
SCHEMBL468549 0.85 TSHR (0.44)
SCHEMBL14754952 0.84 PAOX (0.46)
SCHEMBL28714588 0.80 ALDH1A1 (0.36)
SCHEMBL16745576 0.79
SCHEMBL20343807 0.78 TSHR (0.72)
SCHEMBL339534 0.77 ALDH1A1 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112031-A1 ALL-IN-ONE CELL CONTROL TECHNIQUE BASED ON PHOTOSENSITIVE POLYMER FILM CAPABLE OF ENTIRE PROCESS OF CELL CULTURE, GROWTH PROMOTION, AND CELL SHEET SEPARATION AND DELIVERY 연세대학교 산학협력단 2024-05-30 WO claimed
US-20220152217-A9 TARGETED COMBINATION THERAPY AURA BIOSCIENCES, INC. (US) 2022-05-19 US claimed
US-20210290778-A1 TARGETED COMBINATION THERAPY AURA BIOSCIENCES, INC. (US) 2021-09-23 US claimed
EP-3609520-A1 TARGETED COMBINATION THERAPY Aura Biosciences, Inc. (US) 2020-02-19 EP claimed
EP-2884975-B1 PHOTOTHERAPEUTIC AGENT FOR USE IN A METHOD OF TREATING ONYCHOMYCOSIS DUSA PHARMACEUTICALS INC (US) 2019-07-31 EP claimed
US-10287601-B2 Indole-derived compound production BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) 2019-05-14 US claimed
WO-2018191363-A1 TARGETED COMBINATION THERAPY AURA BIOSCIENCES, INC. (US) 2018-10-18 WO claimed
US-20180127726-A1 STEM CELL REMOVING METHOD, DIFFERENTIATED CELL PROTECTIVE METHOD, AND CULTURE MEDIUM COMPOSITION REPROCELL INCORPORATED (JP) 2018-05-10 US claimed
EP-3282011-A1 METHOD FOR ELIMINATING STEM CELLS, METHOD FOR PROTECTING DIFFERENTIATED CELLS, AND CULTURE MEDIUM COMPOSITION Reprocell Incorporated (JP) 2018-02-14 EP claimed
WO-2018019353-A1 A PHOTOSENSITIZING FORMULA CONTAINING SIMETHICONE AND CHLOROPHYLL AS AN ENVIRONMENTALLY FRIENDLY LARVICIDE AND PUPAECIDE INRAD FOR SCIENTIFIC RESEARCH (EG) 2018-02-01 WO claimed
US-20110144410-A1 Therapy Device and Related Accessories, Compositions, and Treatment Methods PHAROS LIFE CORPORATION (CA) 2011-06-16 US claimed
US-20100297677-A1 CYCOCHROME C SYNTHESIS INHIBITORS THE WASHINGTON UNIVERSITY (US) 2010-11-25 US claimed
US-7790184-B2 Using reporter gene expression profiles as tools to monitor efficacy of protein inhibitors WASHINGTON UNIVERSITY IN ST. LOUIS (US) 2010-09-07 US claimed
US-20080032313-A1 Using reporter gene expression profiles as tools to monitor efficacy of protein inhibitors WASHINGTON UNIVERSITY IN ST. LOUIS (US) 2008-02-07 US claimed
EP-1781329-A1 THERAPY DEVICE AND RELATED ACCESSORIES, COMPOSITIONS, AND TREATMENT METHODS Kennedy, John (CA) 2007-05-09 EP claimed
WO-2006012752-A1 THERAPY DEVICE AND RELATED ACCESSORIES, COMPOSITIONS, AND TREATMENT METHODS KENNEDY JOHN (CA) 2006-02-09 WO claimed
US-20020156361-A1 Positioning template for implanting a substance into a patient POPOWSKI YOURI (CH) 2002-10-24 US claimed
US-6212425-B1 Apparatus for photodynamic diagnosis KARL STORZ GMBH & CO., KG (DE) 2001-04-03 US claimed
EP-0861044-B1 APPARATUS FOR PHOTODYNAMIC DIAGNOSIS STORZ KARL GMBH & CO KG (DE) 2001-03-07 EP claimed
WO-1988008450-A1 GENE THERAPY FOR METABOLITE DISORDERS FINLAYSON BIRDWELL (US) 1988-11-03 WO claimed